Barr Company Profile
✉ Email this page to a colleague
What is the competitive landscape for BARR, and what generic and branded alternatives to BARR drugs are available?
BARR has one hundred and seventy-five approved drugs.
There are seven tentative approvals on BARR drugs.
Drugs and US Patents for Barr
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Barr | CLONAZEPAM | clonazepam | TABLET, ORALLY DISINTEGRATING;ORAL | 077194-005 | Aug 10, 2005 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Barr Labs Inc | DEXTROAMP SACCHARATE,AMP ASPARTATE,DEXTROAMP SULFATE AND AMP SULFATE | amphetamine aspartate; amphetamine sulfate; dextroamphetamine saccharate; dextroamphetamine sulfate | CAPSULE, EXTENDED RELEASE;ORAL | 076536-001 | Feb 12, 2013 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
Barr | LANTHANUM CARBONATE | lanthanum carbonate | TABLET, CHEWABLE;ORAL | 090977-003 | Jan 27, 2022 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.